Overall Technical outlook

Price Summary

Zydus Lifesciences Limited's stock began trading at 984.0 on 2025-10-17, soared to 991.0, dipped to 978.05, and finished the day 0.37% up at 987.65, with 745052 shares exchanged.
The stock's highest value over the last 52 weeks is 1047.85, and the lowest value is 822.1.
Analysts' predictions indicate that ZYDUSLIFE's future price will be between 794.0 and 1150.0, with a mean price expectation of approximately 970.1.

Technicals

Support and Resistance: The price for ZYDUSLIFE is 987.65, with support at 978.8 and resistance at 1023.15. This suggests a range where 978.8 acts as a base, preventing declines, and 1023.15 caps gains, defining key trading levels.
ZYDUSLIFE supportResistance 61ecaa
Support/Resistance for ZYDUSLIFE


Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for ZYDUSLIFE. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
ZYDUSLIFE aroon 61ecaa
Aroon chart for Zydus Lifesciences Limited


Bol. Bands: The BOLL BANDS is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
ZYDUSLIFE bbands 61ecaa
Bolinger Bands chart for Zydus Lifesciences Limited


Parabolic SAR: The PSAR remains in a bearish mode, establishing a resistance level that could hinder any attempts at upward movement for ZYDUSLIFE. This resistance reinforces the bearish sentiment, indicating that the market may continue to face challenges in pushing higher.
ZYDUSLIFE psar 61ecaa
Parabolic Stop and Reverse chart for Zydus Lifesciences Limited


Stochastic: The STOCHASTIC is in a neutral stance for ZYDUSLIFE, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
ZYDUSLIFE stoch 61ecaa
Stochastic chart for Zydus Lifesciences Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
ZYDUSLIFE trippleSMA 61ecaa
Tripple SMA chart for Zydus Lifesciences Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.